Welcome to our dedicated page for Steris news (Ticker: STE), a resource for investors and traders seeking the latest updates and insights on Steris stock.
STERIS plc provides healthcare and life sciences products and services that support patient care, with an emphasis on infection prevention. Its recurring news includes financial results and outlook updates for continuing operations, quarterly dividend actions, conference-call announcements, and board or executive governance changes.
The company’s business updates center on sterilization services, Applied Sterilization Technologies, sterilizers, washer-disinfectors, and decontamination equipment and supplies used by care providers and biopharma manufacturing sites. Corporate announcements also address capital spending, cash flow expectations, and shareholder distribution information.
STERIS plc (NYSE: STE) will host a conference call on August 4, 2020, at 10:00 a.m. ET, to discuss its fiscal 2021 first quarter financial results. The press release detailing these results will be published after market close on August 3, 2020. Interested parties can join the call via the internet or by phone. A replay will be accessible after the live event. STERIS aims to contribute to a healthier world through innovative healthcare and life science solutions.
STERIS plc (NYSE: STE) announced the U.S. FDA has granted an Emergency Use Authorization for their new respirator decontamination method using AMSCO Steam Sterilizers. This allows healthcare providers to decontaminate surgical N95 respirators, enabling up to 30 million respirators per day to be processed. This is STERIS's second EUA, following one for vaporized hydrogen peroxide. The company will install this upgrade free of charge for healthcare facilities that coordinate maintenance.
STERIS reported a strong fourth quarter for fiscal 2020, with revenue increasing 7% to $823 million, driven by growth across all segments. The company achieved a net income of $123.3 million, or $1.44 per diluted share, up from $108.7 million, or $1.27 per diluted share, in Q4 2019. Adjusted net income rose 7% to $140.5 million. Full-year revenue reached $3.2 billion, with net income of $407.6 million. However, due to COVID-19 uncertainties, STERIS is not providing guidance for fiscal 2021. The company declared a quarterly dividend of $0.37 per share.
Summary not available.